Comprehensive review of SGLT2 inhibitors' efficacy through their diuretic mode of action in diabetic patients.
SGLT2 inhibitors
canagliflozin
dapagliflozin
diabetes
diuretic action
efficacy
empagliflozin
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
02
2023
accepted:
08
06
2023
medline:
8
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
SGLT2 inhibitors (SGLT2i) are now the mainstay therapy for both diabetes and heart failure.
Identifiants
pubmed: 37547306
doi: 10.3389/fendo.2023.1174692
pmc: PMC10400285
doi:
Substances chimiques
Canagliflozin
0SAC974Z85
Diuretics
0
Glucosides
0
Sodium-Glucose Transporter 2 Inhibitors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1174692Informations de copyright
Copyright © 2023 Lam-Chung.
Déclaration de conflit d'intérêts
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
ESC Heart Fail. 2020 Dec;7(6):3401-3407
pubmed: 32915523
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
Age Ageing. 2019 Nov 1;48(6):859-866
pubmed: 31579904
JAMA Cardiol. 2021 Feb 1;6(2):148-158
pubmed: 33031522
Circulation. 2021 Feb 2;143(5):438-448
pubmed: 33186054
Diabetes Care. 2018 Feb;41(2):356-363
pubmed: 29203583
JAMA Cardiol. 2021 Jul 1;6(7):801-810
pubmed: 33851953
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
N Engl J Med. 2020 Oct 8;383(15):1425-1435
pubmed: 32966714
N Engl J Med. 2021 Jan 14;384(2):129-139
pubmed: 33200891
Diabetes Obes Metab. 2018 Mar;20(3):479-487
pubmed: 29024278
Circulation. 2020 Sep 15;142(11):1028-1039
pubmed: 32410463
PLoS Med. 2019 Dec 9;16(12):e1002983
pubmed: 31815931
Heart. 2021 Feb 26;:
pubmed: 33637556
Therapie. 2016 Feb;71(1):27-41
pubmed: 27080628
Diabetes Obes Metab. 2019 Apr;21 Suppl 2:9-18
pubmed: 31081592
Lancet. 2019 Jan 5;393(10166):31-39
pubmed: 30424892
Am Heart J. 2019 Dec;218:66-74
pubmed: 31707330
Cardiovasc Diabetol. 2020 Jun 26;19(1):98
pubmed: 32590982
JACC Heart Fail. 2019 Apr;7(4):336-346
pubmed: 30738981
Diabetes Care. 2020 Mar;43(3):508-511
pubmed: 32079684
N Engl J Med. 2019 Jan 24;380(4):347-357
pubmed: 30415602
Hypertension. 2020 Apr;75(4):894-901
pubmed: 32114848
N Engl J Med. 2020 Oct 8;383(15):1436-1446
pubmed: 32970396
Card Fail Rev. 2017 Apr;3(1):52-55
pubmed: 28785476
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
N Engl J Med. 2019 Jun 13;380(24):2295-2306
pubmed: 30990260
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
J Am Coll Cardiol. 2018 Dec 25;72(25):3370-3372
pubmed: 30409566
Diabetes Obes Metab. 2013 Sep;15(9):853-62
pubmed: 23668478